Characteristics of us adults attempting tobacco use cessation using e-cigarettes.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
01 2020
Historique:
received: 19 04 2019
revised: 04 09 2019
accepted: 04 09 2019
pubmed: 13 10 2019
medline: 16 1 2021
entrez: 13 10 2019
Statut: ppublish

Résumé

Use of e-cigarettes for tobacco cessation efforts is a growing trend in the United States. However, little is known about the factors that determine the use of e-cigarettes for this specific purpose. This study examined current and former cigarette smokers that reported ever using e-cigarettes. Data were obtained from a 2018 Texas population health assessment survey (n = 569) and weighted to be representative to Texas. A multivariable logistic regression was used to assess the socio-demographic and behavioral correlates of using e-cigarettes for tobacco cessation. Overall, 41.3% of e-cigarette users reported using them for tobacco cessation. Among ever e-cigarette users, Non-Hispanic blacks (aOR: 0.21; 95% CI, 0.07-0.64), males (aOR: 0.40; 95% CI, 0.20-0.80), and individuals not confident in obtaining health information (aOR: 0.38; 95% CI, 0.15-0.96) were less likely to use e-cigarettes for tobacco use cessation. Conversely, among ever e-cigarette users, odds of using e-cigarettes for tobacco cessation were higher among those who were 35-44 years old (aOR: 3.68, 95% CI: 1.26-10.71), those who received advice to quit smoking from a healthcare professional (aOR: 2.77, 95% CI, 1.36-5.64), and those with more than 5 years since their last routine checkup (aOR: 3.91; 95% CI, 1.23-12.45). Findings from this study suggest that both health behaviors and sociodemographic factors predict use of e-cigarettes for the purpose of tobacco cessation. Furthermore, the relationship between use of e-cigarettes as a cessation device and being advised to quit tobacco use by a healthcare professional calls for additional investigation.

Sections du résumé

BACKGROUND
Use of e-cigarettes for tobacco cessation efforts is a growing trend in the United States. However, little is known about the factors that determine the use of e-cigarettes for this specific purpose.
METHODS
This study examined current and former cigarette smokers that reported ever using e-cigarettes. Data were obtained from a 2018 Texas population health assessment survey (n = 569) and weighted to be representative to Texas. A multivariable logistic regression was used to assess the socio-demographic and behavioral correlates of using e-cigarettes for tobacco cessation.
RESULTS
Overall, 41.3% of e-cigarette users reported using them for tobacco cessation. Among ever e-cigarette users, Non-Hispanic blacks (aOR: 0.21; 95% CI, 0.07-0.64), males (aOR: 0.40; 95% CI, 0.20-0.80), and individuals not confident in obtaining health information (aOR: 0.38; 95% CI, 0.15-0.96) were less likely to use e-cigarettes for tobacco use cessation. Conversely, among ever e-cigarette users, odds of using e-cigarettes for tobacco cessation were higher among those who were 35-44 years old (aOR: 3.68, 95% CI: 1.26-10.71), those who received advice to quit smoking from a healthcare professional (aOR: 2.77, 95% CI, 1.36-5.64), and those with more than 5 years since their last routine checkup (aOR: 3.91; 95% CI, 1.23-12.45).
CONCLUSION
Findings from this study suggest that both health behaviors and sociodemographic factors predict use of e-cigarettes for the purpose of tobacco cessation. Furthermore, the relationship between use of e-cigarettes as a cessation device and being advised to quit tobacco use by a healthcare professional calls for additional investigation.

Identifiants

pubmed: 31605837
pii: S0306-4603(19)30462-9
doi: 10.1016/j.addbeh.2019.106123
pmc: PMC6905082
mid: NIHMS1544084
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106123

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
Arch Intern Med. 2010 Oct 11;170(18):1640-6
pubmed: 20937922
J Behav Med. 1987 Apr;10(2):129-37
pubmed: 3612774
Am J Prev Med. 2015 Dec;49(6):939-44
pubmed: 26362404
Curr Opin Psychol. 2015 Oct;5:78-84
pubmed: 26213711
BMJ. 2016 Sep 13;354:i4645
pubmed: 27624188
Addiction. 2011 Nov;106(11):2017-28
pubmed: 21592253
Prev Med. 2014 Dec;69:90-4
pubmed: 25230365
PLoS One. 2015 Mar 30;10(3):e0122544
pubmed: 25822251
Am J Prev Med. 2017 Nov;53(5):652-660
pubmed: 28864130
Int J Environ Res Public Health. 2014 Oct 03;11(10):10345-61
pubmed: 25286168
Addiction. 2014 Sep;109(9):1531-40
pubmed: 24846453
Am J Health Behav. 2017 Nov 1;41(6):750-759
pubmed: 29025503
BMJ. 2017 Jul 26;358:j3262
pubmed: 28747333
Lancet. 2015 Sep 26;386(10000):1237
pubmed: 26338257
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Transl Behav Med. 2013 Jun;3(2):211-7
pubmed: 23894256
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):428-430
pubmed: 30647064
PLoS One. 2013 Jun 24;8(6):e66317
pubmed: 23826093
Tob Control. 2015 Jul;24(4):341-7
pubmed: 24532710
BMJ. 1998 Jun 20;316(7148):1878-81
pubmed: 9632409
Cochrane Database Syst Rev. 2016 Sep 14;9:CD010216
pubmed: 27622384
Harm Reduct J. 2018 Jun 20;15(1):31
pubmed: 29921278
Tob Control. 2016 Oct;25(Suppl 1):i90-i95
pubmed: 27697953
BMC Public Health. 2014 Jul 14;14:716
pubmed: 25018151
Psychol Addict Behav. 2015 Mar;29(1):114-21
pubmed: 25180551
Addict Behav. 2018 Jan;76:129-134
pubmed: 28802179
JAMA. 2018 May 15;319(19):2039-2041
pubmed: 29800201
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):486-494
pubmed: 30700446
Nicotine Tob Res. 2010 Oct;12(10):1050-4
pubmed: 20819787
Int J Environ Res Public Health. 2017 Nov 17;14(11):
pubmed: 29149048
MMWR Morb Mortal Wkly Rep. 2018 Nov 09;67(44):1225-1232
pubmed: 30408019
Addict Behav. 2014 Jun;39(6):1120-5
pubmed: 24679611
Nicotine Tob Res. 2015 Oct;17(10):1219-27
pubmed: 25542911
Am J Public Health. 2013 Jul;103(7):e43-9
pubmed: 23678912
Am J Prev Med. 2011 Apr;40(4):472-5
pubmed: 21406283

Auteurs

Onyema Greg Chido-Amajuoyi (OG)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, USA.

Dale Mantey (D)

Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Sonia Cunningham (S)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Robert Yu (R)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Steven Kelder (S)

Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Ernest Hawk (E)

Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, USA.

Paul Cinciripini (P)

Department of Behavioral Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Sanjay Shete (S)

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: sshete@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH